Though the focus at ThoughtSpot 2015 has been on AmerisourceBergen’s independent pharmacy customers, the company is shifting its focus to issues that are front and center in the minds of its chain customers with the National Association of Chain Drug Stores’ Total Store Expo just three weeks away.
There aren’t many places an independent pharmacist can gain access to more than 300 vendors, as many as 60 hours of continuing education and the kind of new pharmacy tools and services that will not only help independent community pharmacists stay in the game, but may help them improve on that game by a notch or two. But that’s exactly what AmerisourceBergen had on its show card for the 4,000 attendees at ThoughtSpot 2015, held in Las Vegas at the MGM Grand.
The common saying goes what happens in Vegas, stays in Vegas — but that’s not true if you’re coming back from Good Neighbor Pharmacy’s ThoughtSpot 2015 annual meeting. For them, what happened this year in Vegas will help enhance their pharmacy operations for years to come. Drug Store News, with the help of AmerisourceBergen’s top brass, identified the three ThoughtSpot takeaways Good Neighbor Pharmacy owners will be implementing on the Monday they’re back from the show.
Topeka Pharmacy was named the Good Neighbor Pharmacy of the Year winner here at AmerisourceBergen ThoughtSpot 2015’s General Session. Topeka Pharmacy — which serves Topeka, Ind., a town of about 1,100 people that’s 60% Amish and has a single stoplight — garnered more online votes than Santa Monica, Calif.-based McCarthy Pharmacy and Bayshore Pharmacy in Atlantic Highlands, N.J.
The Centers for Medicare and Medicaid Services this week announced that they expect the average premium for a basic Medicare Part D prescription drug plan in 2016 to remain stable at about $32.50 per month.
The National Association of Chain Drug Stores commented on the proposed regulations on the use of managed care in Medicaid and in the Children’s Health Insurance Program, urging "to maintain the strong link between Medicaid patients and community pharmacies and the valuable services that these pharmacies provide."
In late July, the Government Accountability Office released a report on how the lack of effective communications between the Drug Enforcement Agency and both pharmaceutical distributors and chain pharmacy headquarters has impacted legitimate access to pain medicines. "The agency’s report further validates the need for bipartisan, bicameral legislation," according to NACDS.
Bartell Drugs announced Thursday that it is inviting donations of school supplies and hygiene products for its 12th annual “School Tools for Kids in Need,” from Aug. 2 through Aug. 29 at all 64 Bartell Drugs locations.
McKesson on Thursday reported increased revenues for the first quarter, which ended June 30. At $47.5 billion, revenues were up 9%, compared with $43.5 billion a year ago. First-quarter earnings per diluted share from continuing operations was $2.50 compared with $1.76 a year ago.
Drug Store News, in partnership with consumer health engagement company higi, has announced that Marlena Kelley, pharmacy manager at Publix’s Daphne, Ala., location, is the grand prize winner of its June 2015 Fit Pharmacist Challenge, sponsored by Splenda.
Fifty years ago this summer, President Lyndon B. Johnson secured his place in history by signing into law the legislation that created Medicare and Medicaid. To commemorate the anniversary, Drug Store News has put together an exclusive report on the effect that Medicare and Medicaid have had on the retail pharmacy industry and how it has transformed the role of the pharmacist.
The Consumer Healthcare Products Association expressed support for the DXM Abuse Prevention Act, introduced into the U.S. House of Representatives by U.S. Reps. Bill Johnson, R-Ohio, and Doris Matsui, D-Calif., on Wednesday.
The DEA announced on Tuesday that the 10th National Prescription Drug Take-Back will take place across the United States on Sept. 26 — except for in Pennsylvania and Delaware where the event will take place on Sept. 12.
Hikma Pharmaceuticals on Wednesday announced its acquisition of Roxane Laboratories and Boehringer Ingelheim Roxane (together, “Roxane” — an American specialty generics company) from Boehringer Ingelheim for about $2.65 billion.
Mylan on Wednesday announced that it received unconditional clearance from the European Commission under the European Union Merger Regulation for its acquisition of Perrigo Co., an Irish international manufacturer of private-label over-the-counter pharmaceuticals.